TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • February 28, 2019

JOONDALUP, Australia—AusCann, a medical cannabis supplier, has chosen PCI Pharma Services, Rockford, IL, to manufacture its first medicinal cannabis product to treat chronic pain. PCI will manufacture the hard-shell capsule product at its Australian manufacturing facilities. The solid dosage cannabis product offers a consistent, stable, and easy-to-administer oral dosage form for the estimated 1.9 million Australians suffering from chronic neuropathic pain.